Human urine stimulates in vitro growth of Trypanosoma cruzi and Trypanosoma rangeli

Parasitology Research

Volumn 101, Issue 5, 2007, Pages 1383-1388

  Ferreira, Keila A M ^a   Lemos Jr , Paulo E S ^a   Lages Silva, Eliane ^a   Ramírez, Luis E ^a   Pedrosa, André L ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GROWTH CURVE; IN VITRO STUDY; LEISHMANIA; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE; URINE;

ANIMALS; CULTURE MEDIA; HUMANS; TRYPANOSOMA; URINE;

TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI;

EID: 34548593089     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-007-0654-0     Document Type: Article

References (30)

1. Ali SA, Iqbal J, Ahmad B, Masoom M (1998) A semisynthetic fetal calf serum-free liquid medium for in vitro cultivation of Leishmania promastigotes. Am J Trop Med Hyg 59:163-165
2. Armstrong TC, Patterson JL (1994) Cultivation of Leishmania braziliensis in an economical serum-free medium containing human urine. J Parasitol 80:1030-1032
3. Avila JL, Perez-Kepp R, Bretana A (1983) A minimal medium for the cultivation of infective Trypanosoma cruzi epimastigotes. J Gen Microbiol 129:285-291
4. Camargo EP (1964) Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop São Paulo 12:93-100
5. Chaudhuri G, Ghoshal K, Pal S, Sen S, Banerjee AB (1986) A new medium for large scale production of Leishmania donovani promastigotes for biochemical studies. Indian J Med Res 84:457-460
6. Childs GE, McRoberts MJ, Moussa MA (1979) Systems for the in vitro large-scale propagation of New World Leishmania. Ann Trop Med Parasitol 73:395-396
7. Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S (1985) In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol 16:315-327
8. Coura JR, Fernandes O, Arboleda M, Barrett TV, Carrara N, Degrave W, Campbell DA (1996) Human infection by Trypanosoma rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 90:278-279
9. Cuba Cuba A (1998) Review of the biologic and diagnostic aspects of Trypanosoma (Herpetosoma) rangeli. Rev Soc Bras Med Trop 31:207-220
10. D'Alessandro A, Saravia NG (1992) Trypanosoma rangeli. In: Kreier JP, Baker JR (eds) Parasitic protozoa. Academic Press, San Diego
11. Engel JC, Dvorak JA, Segura EL, Crane MS (1982) Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium. J Protozool 29:555-560
12. Guhl F, Vallejo GA (2003) Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review. Mem Inst Oswaldo Cruz 98:435-442
13. Hendricks LD, Wood DE, Hajduk ME (1978) Haemoflagellates: commercially available liquid media for rapid cultivation. Parasitology 76:309-316
14. Hide G, Gray A, Harrison CM, Tait A (1989) Identification of an epidermal growth factor receptor homologue in trypanosomes. Mol Biochem Parasitol 36:51-59
15. Howard MK, Sayers G, Miles MA (1987) Leishmania donovani. metacyclic promastigotes: transformation in vitro, lectin agglutination, complement resistance, and infectivity. Exp Parasitol 64:147-156
16. Howard MK, Pharoah MM, Ashall F, Miles MA (1991) Human urine stimulates growth of Leishmania in vitro. Trans R Soc Trop Med Hyg 85:477-479
17. Kar K, Mukerji K, Naskar K, Bhattacharya A, Ghosh DK (1990) Leishmania donovani: a chemically defined medium suitable for cultivation and cloning of promastigotes and transformation of amastigotes to promastigotes. J Protozool 37:277-279
18. Koerich LB, Emmanuelle P, Santos K, Grisard EC, Steindel M (2002) Differentiation of Trypanosoma rangeli: high production of infective trypomastigote forms in vitro. Parasitol Res 88:21-25
19. Luz ZM, Coutinho MG, Cancado JR, Krettli AU (1994) Hemoculture: sensitive technique in the detection of Trypanosoma cruzi in chagasic patients in the chronic phase of Chagas disease. Rev Soc Bras Med Trop 27:143-148
20. Merlen T, Sereno D, Brajon N, Rostand F, Lemesre JL (1999) Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. Am J Trop Med Hyg 60:41-50
21. O'Daly JA, Rodriguez MB (1988) Differential growth requirements of several Leishmania spp. in chemically defined culture media. Acta Trop 45:109-126
22. Ramirez LE, Lages-Silva E, Alvarenga-Franco F, Matos A, Vargas N, Fernandes O, Zingales B (2002) High prevalence of Trypanosoma rangeli and Trypanosoma cruzi in opossums and triatomids in a formerly-endemic area of Chagas disease in Southeast Brazil. Acta Trop 84:189-198
23. Saldaña A, Sousa OE (1996) Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. J Parasitol 82:363-366
24. Shamsuzzaman SM, Furuya M, Korenaga M, Imamura K, Hashiguchi Y (1999) Use of urine samples from healthy humans, nephritis patients or other animals as an alternative to foetal calf serum in the culture of Leishmania (L.) donovani in vitro. Ann Trop Med Parasitol 93:613-620
25. Slazyk WE, Spierto FW (1990) Liquid-chromatographic measurement of biopterin and neopterin in serum and urine. Clin Chem 36:1364-1368
26. Takle GB, Young A (1988) A simple semi-defined culture medium for the growth of Trypanosoma rangeli. Trans R Soc Trop Med Hyg 82:247
27. Trager W (1969) Pteridine requirement of the hemoflagellate Leishmania tarentolae. J Protozool 16:372-375
28. Vasquez JE, Krusnell J, Orn A, Sousa OE, Harris RA (1997) Serological diagnosis of Trypanosoma rangeli infected patients. A comparison of different methods and its implications for the diagnosis of Chagas' disease. Scand J Immunol 45:322-330
29. WHO The World Health Report (2002) Control of Chagas disease. World Health Organization, Geneva
30. Zeledon R (1959) Differentiation of Trypanosoma rangeli and Schizotrypanum cruzi in a liquid medium, with notes on the nutrition of flagellates. J Parasitol 45:652